Keywords
Virus, CRISPR technology, RNA interference, microRNA, Human Disease, High Throughput Screening
Robert Jan Lebbink is a graduate of the Wageningen University in The Netherlands where he received his Master of Science in Molecular sciences. He obtained his PhD in Immunology in the lab of Linde Meyaard at the University Medical Center in Utrecht The Netherlands, where he studied the role of the inhibitory immune receptor LAIR-1 in immune regulation. Robert Jan develops lentiviral shRNA libraries and exploits these novel tools to identify new players in various biological systems in immune cells.
